Neoadjuvant TherapyPancreatic NeoplasmsCombined Modality TherapyChemotherapy, AdjuvantNeoplasm StagingAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeChemoradiotherapy, AdjuvantAdenocarcinomaPancreatectomyPancreaticoduodenectomyRadiotherapy, AdjuvantPreoperative CareFluorouracilCA-19-9 AntigenRectal NeoplasmsEsophageal NeoplasmsSurvival RateLiver NeoplasmsEsophagectomyCarcinoma, Pancreatic DuctalCisplatinHepatectomyNeoplasm Recurrence, LocalPrognosisLung NeoplasmsDeoxycytidineDisease-Free SurvivalSurvival AnalysisCarcinoma, Squamous CellHypopharyngeal NeoplasmsRetrospective StudiesMetastasectomyPeritoneal LavageColorectal NeoplasmsCarcinoma, Non-Small-Cell LungTomography, X-Ray ComputedInduction ChemotherapyRadiotherapy DosageLeucovorinKaplan-Meier EstimateStomach NeoplasmsGastrectomyOrganoplatinum CompoundsChemoradiotherapyPneumonectomyEsophagogastric JunctionAmpulla of VaterFollow-Up StudiesLaryngectomyAntimetabolites, AntineoplasticBile Duct NeoplasmsOropharyngeal NeoplasmsEndosonographyProspective StudiesLymphatic MetastasisPositron-Emission TomographyRadiotherapyHepatoblastomaTumor Markers, BiologicalDigestive System Surgical ProceduresCholangiocarcinomaMultivariate AnalysisFluorodeoxyglucose F18Carcinoma, Acinar CellPredictive Value of TestsSarcomaRandomized Controlled Trials as TopicLymph Node ExcisionNeoplasm MetastasisNeoplasm SeedingCarcinoma, Large CellMultimodal ImagingFeasibility StudiesPancreatitis, ChronicRetroperitoneal NeoplasmsMediastinumAntineoplastic AgentsLaryngeal NeoplasmsDose FractionationTime FactorsChemoembolization, TherapeuticCarcinoma, HepatocellularTaxoidsRadiotherapy, Intensity-ModulatedCarcinoembryonic AntigenProportional Hazards ModelsInfusions, Intra-ArterialCommon Bile Duct NeoplasmsPeritoneal NeoplasmsCarcinomaPostoperative ComplicationsDrug Administration SchedulePatient SelectionRadiopharmaceuticalsHead and Neck NeoplasmsSensitivity and SpecificityPostoperative CareBile Ducts, IntrahepaticGallbladder Neoplasms